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Abstract
The biological mechanisms that give rise to age-related hearing loss (ARHL) are still poorly
understood. However, there is growing recognition that oxidative stress may be an important
factor. To address this issue, we measured the changes in the expression of cochlear oxidative
stress and antioxidant defense-related genes in young (2 months old), middle-aged (12 months
old), and old (21–25 months old) Fischer 344/NHsd (F344/NHsd) rats and compared gene
expression changes with ARHL. A quantitative real-time reverse transcription polymerase chain
reaction array revealed a significant age-related downregulation of only 1 gene, stearoyl-coenzyme
A desaturase 1, and upregulation of 12 genes: 24-dehydrocholesterol reductase; aminoadipate-
semialdehyde synthase; cytoglobin; dual oxidase 2; glutathione peroxidase 3; glutathione
peroxidase 6; glutathione S-transferase, kappa 1; glutathione reductase; nicotinamide adenine
dinucleotide phosphate (NAD(P)H) dehydrogenase, quinone 1; solute carrier Family 38, Member
5; thioredoxin interacting protein; and vimentin. Statistical analyses revealed significant
correlations between gene expression and auditory function in 8 genes. Our results identified
specific subsets of oxidative stress genes that appear to play an important role in ARHL in the
Fischer 344/NHsd rat.
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1. Introduction
Reactive oxygen species (ROS) that are generated during normal metabolism can be
effectively eliminated by cellular antioxidant defense mechanisms. Excessive production of
ROS, however, overwhelms the antioxidant defense system, leading to oxidative stress and
tissue damage as seen in noise-induced hearing loss (Henderson et al., 2006). Increased free
radical activity and oxidative stress have been proposed as key determinants of the aging
process (Harman, 1956; Sohal and Weindruch, 1996) and tissue degeneration in aging
mouse cochleae (Jiang et al., 2007; Staecker et al., 2001).
Mitochondria in particular are considered to be a major source of ROS overproduction in
aging tissues (Harman, 1972), and excessive ROS could damage mitochondrial structures
and molecules, leading to DNA mutations or deletions. Emerging evidence shows
mitochondrial damage in age-related hearing loss (ARHL) in humans (Markaryan et al.,
2008) and in various animal models, including DBA/2J and Polg(D257A) knockin mice
(Someya et al., 2007; Yamasoba et al., 2007), and Fisher 344/NHsd (F344/NHsd) rats
(Seidman et al., 2000; Yin et al., 2007).
The F344/NHsd rat exhibits increased mitochondrial DNA deletions in the cochlea at 6 and
9 months of age (Seidman et al., 2000; Yin et al., 2007). The accumulation of mitochondrial
DNA deletions or mutations during aging is thought to impair mitochondrial function,
resulting in the buildup of cochlear oxidative stress and consequent cochlear degeneration
and ARHL (Fig. 1).
The antioxidant defense system is our natural defense against oxidative stress. To
understand the role of antioxidant enzymes in the aging degeneration, 2 studies have
examined changes in the level of cochlear antioxidant enzyme activity in aging F344/NHsd
cochlea (Coling et al., 2009; Lautermann et al., 1997). Compared with 3-monthold rats, 24-
month-old F344/NHsd rats exhibit decreased glutathione levels in the auditory nerve.
However, enzyme activities of glutathione reductase (Gsr) and glutathione S-transferase
(Gst) remained unchanged in the cochlear sensory epithelium (CSE), the lateral wall (LW),
auditory nerve, and the vestibular system (Lautermann et al., 1997). Mean glutathione
peroxidase (Gpx) activity in the CSE, LW, and auditory nerve increased in the 24-month-old
F344/NHsd rats, but the increase was not statistically significant. Another study (Coling et
al., 2009) reported a statistically significant increase in Gpx in the LW, but not in the
auditory nerve or CSE, suggesting that age-related changes in activities of these enzymes
appear to be tissue specific.
Changes in antioxidant capacity are likely to be caused by expression changes in antioxidant
enzymes and molecules. So far, only 1 study has examined age-related changes in
antioxidant enzyme gene expression in F344/NHsd rats (Chen and Ruan, 2009). However,
this study revealed no significant changes in Cu/Zn-superoxide dismutase (Sod1), Mn-Sod
(Sod2), catalase, or Gpx1 in either the auditory cortex or the cochleae. Therefore, a
comprehensive analysis of expression patterns of the genes related to oxidative stress and
antioxidant defense is necessary.
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Human ARHL or presbycusis has been categorized into 6 types (Schuknecht and Gacek,
1993): (1) sensory presbycusis, caused primarily by loss of outer hair cells (OHCs) in the
basal end of the cochlea; (2) neural presbycusis, characterized by degeneration of cochlear
neurons; (3) strial or metabolic presbycusis, with degeneration in stria vascularis; (4)
cochlear conductive presbycusis, hypothetically associated with changes in the stiffness
properties of the basilar membrane; (5) mixed presbycusis, a combination of different
pathologies; and (6) indeterminate presbycusis, with no obvious cellular pathology,
indicating a possibility of impaired cellular function rather than cellular attrition.
To investigate these types of hearing loss, several animal species such as mice, rats,
chinchillas, gerbils, and guinea pigs, have been used. Each animal model mimics distinct
types of human presbycusis. For example, mice are reported to mimic all types of
presbycusis, except for cochlear conductive and indeterminate presbycusis; and rats mimic
all types, except for cochlear conductive presbycusis (see Ohlemiller, 2006, 2009 and Syka,
2010 for reviews).
The F344 inbred albino rat, with a median life span of 28–31 months (Chesky and
Rockstein, 1976; Rao and Boorman, 1990), is widely used as an animal model of aging and
ARHL. Despite the extensive use of the F344, genetic contributions to ARHL in the F344
are still not well understood and need to be investigated. The F344 was originally bred as a
natural cancer model at Columbia University (Festing, 1979; Tanaka et al., 2000). Later, the
F344 that was brought to the National Cancer Institute was denoted as F344/N and
distributed in the USA. The substrain that went to the Charles River Laboratory was denoted
as F344/Du and used in Europe for research.
Both the F344/NHsd and F344/DuCrl, which are used in ARHL research, initially develop
high-frequency hearing loss that gradually progresses to the low-frequencies later in their
lives (Bielefeld et al., 2008; Popelar et al., 2006). The deterioration of auditory function in
F344/DuCrl rats is accompanied by pathological changes in the cochlea, including the loss
of OHCs, decreased immunostaining of collagen, and fibrocytes in spiral ligament. Possible
changes in the collagen of the tympanic membrane were also suggested (Buckiova et al.,
2006, 2007; Popelar et al., 2006; Syka, 2010). These investigators also reported high
numbers of apoptotic cells in the stria vascularis in 20- to 24-month-old F344/DuCrl rats,
suggesting a possibility of abnormal endocochlear potentials (EPs). In contrast, F344/NHsd
rats have normal endocochlear potentials at the same age. The differences in cochlear
pathologies between the 2 substrains are difficult to assess because the 2 substrains have not
been studied simultaneously in 1 laboratory.
The F344/NHsd substrain develops hearing loss starting in the 20–40 kHz range between 9
and 12 months of age, extending down to 5–10 kHz by 18 months of age (Bielefeld et al.,
2008). Age-related decreases in distortion product otoacoustic emission (DPOAE)
amplitudes were observed in both substrains. Cochlear pathologies in F344/NHsd rats
include the loss of OHCs (Bielefeld et al., 2008; Hu et al., 2008) and spiral ganglion cells
(SGCs) in the basal and middle turns (Keithley et al., 1992).
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In 20- to 27-month-old F344/NHsd rats, OHCs were present in the middle to upper basal
turn, but surprisingly, DPOAE amplitudes in these regions were reduced in the aged F344/
NHsd rats. These results suggest that functional impairments occur long before OHC
degeneration (Bielefeld et al., 2008; Chen et al., 2009). In addition, a reduction in DPOAE
amplitudes in the aged F344/NHsd rats was associated with reduced immunolabeling of the
OHC electromotility protein, prestin (Chen et al., 2009), which is believed to underlie
cochlear amplification and DPOAE generation (Liberman et al., 2002; Zheng et al., 2000).
The reduced prestin immunolabeling led to the hypothesis that the F344/NHsd rat is a model
of indeterminate presbycusis because hearing loss results from OHC malfunction rather than
OHC loss.
While the physiological and pathological changes in aging F344/NHsd rats have been
relatively well documented, the molecular mechanisms responsible for these changes are
still not clear. Given the importance of oxidative imbalances in ARHL, we designed the
study to screen genes related to oxidative stress and antioxidant defenses for their
involvement in the cochlear aging process. Gene expression changes in cochlear tissue were
measured at several different ages in F344/NHsd rats using a quantitative real-time reverse
transcription polymerase chain reaction (RT-qPCR) array containing 84 relevant genes. In
addition, the gene expression changes were tested for correlation with changes in hearing
function as assessed with DPOAE and the auditory brainstem response (ABR). The current
study will serve as the first phase to identify significant cochlear genes in oxidative stress
and antioxidant defense pathway in relation to ARHL. Our results recognized specific
subsets of oxidative stress genes that appear to play an important role in ARHL in the F344/
NHsd rat.
2. Methods
2.1. Subjects
Three groups of F344/NHsd inbred male albino rats, young (2 months old, n = 10), middle-
aged (12 months old, n = 8), and old (21–25 months old, n = 10), were obtained from Harlan
Laboratories, Inc., National Institute of Aging (Bethesda, MD, USA, for the old age group)
and Taconic Farms, Inc. (Germantown, NY, USA, for the young and middle age groups).
All procedures involving use and care of the animals were reviewed and approved by the
State University of New York at Buffalo Institutional Animal Care and Use Committee.
2.2. ABR test
The animals were anesthetized with inhalant isoflurane (4% for induction, 1.5% for
maintenance, 1 L per minute O2 flow rate). ABR recordings were performed in a
soundproof booth. Subcutaneous needle electrodes were placed at the vertex (noninverting),
below the left pinna (inverting), and behind the shoulder blade (ground). During the ABR
recordings, the animals were placed on a homeothermic blanket (Model 50–7053-F, Harvard
Apparatus, Holliston, MA, USA) to maintain body temperature. Test stimuli consisted of
alternating phase tone bursts at frequencies of 5, 10, 15, 20, 30, and 40 kHz. Signals were
generated using Tucker Davis Technologies (TDT, Gainesville, FL, USA) SigGen32
software. Each tone burst (1-ms duration) was gated with a Blackmann window that had a
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0.5 ms rise/fall time with no plateau. Stimuli were presented at a rate of 21 per second.
Signals were routed to a Dome tweeter (model FT28D, Fostex, Tokyo, Japan) positioned at
0 degrees azimuth, 17 cm from the vertex of each animal’s head. The signals were calibrated
before the testing sessions. The animals’ evoked responses were amplified with a gain of
50,000 times, using a TDT Headstage-4 bioamplifier and bandpass filtered from 100 to 3000
Hz. Responses to 300 sweeps were averaged at each stimulus level using TDT BioSig32
software. The level of the signals was decreased in 5-dB steps from 90 dB sound pressure
level (SPL) to 10 dB below that of the lowest level that evoked a detectable and repeatable
response. Threshold was defined as the lowest level at which a detectable response could be
elicited and could be repeated.
2.3. DPOAE
While the rats were under isoflurane anesthesia, DPOAEs were recorded using a
SmartDPOAE System (Version 4.53, Intelligent Hearing System, Miami, FL, USA) in a
sound-attenuating chamber. During the DPOAE recording, the animals were placed on a
homoeothermic blanket. Otoscopic examinations were performed prior to testing to identify
the presence of any cerumen. An earpiece attached to a microphone (Etymotic10B, Etymotic
Research, Inc., Elk Grove Village, IL, USA) and 2 sound delivery tubes were inserted into
the ear canal. Two IHS-3738 high-frequency transducers (Intelligent Hearing System) were
used to deliver the 2 primary tones, F1 and F2, to the ear canal via the 2 flexible tubes
connected to the earpiece. The F2/F1 ratio was set at 1.2, with 10 dB difference between F1
and F2 intensities (L1 and L2, respectively). The output of the microphone was fed to the
input of the Smart DPOAE system, digitized, and evaluated using the system software.
Cubic DPOAEs were measured at the frequency of 2F1–F2. The intensity of F1 was
decreased in 5-dB steps from 70 to 25 dB SPL. At least 2 runs were recorded from each ear,
and the average amplitude from the 2 ears, using the run with the higher amplitude in the 2
runs was used for final analyses.
2.4. Cochleogram
Cytocochleograms were constructed by counting the number of OHCs in 9 cochleae (n = 3
per group). The cochleae were fixed with 10% buffered formalin for 2 hours and then
transferred to phosphate buffered saline (PBS) for dissection. The dissected sensory
epithelium was permeabilized in 0.5% Triton X-100 in PBS for 30 minutes and placed in
Blocker Casein in PBS (Thermo Fisher Scientific, Inc., Rockford, IL, USA) for 2 hours. The
specimens were incubated in antiprestin antibody (C-16, goat polyclonal IgG, catalog
number sc-22694, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at a concentration
of 0.4 μg/mL in PBS containing 5 mg/mL bovine serum albumin (PBSB) overnight at 4 °C
and then in the fluorescein-conjugated secondary antibody (donkey antigoat Alexa 488,
diluted 1:500 in PBSB, Invitrogen Corp., Carlsbad, CA, USA) for 1 hour at room
temperature. The tissues were colabeled with propidium iodide (PI, 5 μg/mL in PBS
containing 0.25% Triton-X-100 and 1% bovine serum albumin, Invitrogen Corp.) for 5
minutes for nuclear staining. The stained specimens were mounted on slides with ProLong
gold antifade reagent (Invitrogen Corp.). The OHCs were judged as absent if both prestin
and propidium iodide fluorescent signals were undetectable.
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2.5. qRT-PCR array
The Rat Oxidative Stress and Antioxidant Defense RT2 Profiler PCR Array (catalog number
PARN-065A, SABiosciences Corp., Frederick, MD, USA) was used to measure the
messenger ribonucleic acid (mRNA) expression levels of oxidative stress and antioxidant
defense-related genes in the cochlear tissues (see Supplementary data for the complete gene
list). The RT2 Profiler PCR Array (SABiosciences Corp.) is a commercially available set of
optimized RT-qPCR primer assays on a 96-well plate that covers different biological
pathways (Hu et al., 2009; Joyce et al., 2011).
The array contains 84 primer pairs of oxidative stress and antioxidant defense pathway-
focused genes and 5 primers of housekeeping genes: ribosomal protein, large, P1 (Rplp1),
hypoxanthine phosphoribosyltransferase 1 (Hprt1), ribosomal protein L13A (Rpl13a),
lactate dehydrogenase A (Ldha), and actin, beta (Actb). Seven wells were used to test
nontranscribed genomic DNA contamination and PCR performance.
2.6. Tissue collection and RNA preparation
One array required purified RNAs from both cochleae in each animal. Four arrays from 4
different animals per group (4 biological replicates) were run and analyzed. Animals were
deeply anesthetized with CO2 and decapitated at least 9 days after functional testing. The
cochleae were quickly removed and perfused through the round window with RNAlater
(Qiagen, Valencia, CA, USA) to preserve RNAs. The cochleae were carefully dissected in
RNAlater to collect and pool the CSE and the LWs from the 2 cochleae of each animal.
Total RNA was extracted using the Qiagen RNeasy Micro Kit after tissue homogenization.
RNA quantity and quality were evaluated with a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific, Wilmington, DE, USA) and an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA, USA). All samples demonstrated good quality RNA (A260/
A280 > 1.8 and RNA integrity number (RIN) > 7.5). RIN (Agilent Technologies) is an index
of RNA quality based on features of capillary electrophoretograms, with RIN 0 as the most
degraded and 10 as the most intact.
2.7. cDNA synthesis and RT-qPCR
Upon completion of total RNA extraction, first-strand cDNA was synthesized using 250 ng
total RNA from each sample and oligo-dT primed reverse transcription (RT2 first strand kit,
C-03, SABiosciences Corp.) according to the manufacturer’s instructions. cDNA product
was used in the RT-qPCR array immediately after synthesis.
Gene arrays were processed according to the manufacturer’s instructions. First, RT2 SYBR
Green/fluorescein qPCR Master Mix (PA-011-12, SABiosciences Corp.) was mixed with
cDNA product. Then 25 μL of the aliquot mixture was loaded onto each well of a 96-well
array. Real-time RT-qPCR on the array was performed using the Bio-Rad MyiQ Single-
Color Real-Time PCR Detection System (MyiQ Optical Module, Bio-Rad Laboratories,
Inc., Hercules, CA, USA). The PCR reaction was run with a 2-step cycling program (1 cycle
at 95 °C for 10 minutes for initial denaturation; 40 cycles consisting of 15 seconds at 95 °C
for denaturing, and 1 minute at 60 °C for annealing).
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Upon completion of the PCR run, threshold cycle (Ct) values were calculated using default
conditions of the iQ5TM Optical System Software (Version 2.1, Bio-Rad Laboratories,
Inc.). The mean threshold of all genes on all arrays was used to obtain Ct values for all
genes. Four biological replications of the real-time RT-qPCR were obtained per group to
calculate p-values. RT-qPCR efficiency was evaluated by the array-implemented testing and
was approximated by the shape of the logarithmic PCR amplification plot (Schmittgen and
Livak, 2008), which suggested good efficiency in all arrays.
2.8. Statistical analysis
A 2-way analysis of variance (ANOVA) was employed to assess differences in ABR
thresholds (group × frequency) and DPOAE amplitudes (group × F2 intensity) using
GraphPad Prism 5 software (Version 5.01, GraphPad Software Inc., La Jolla, CA).
Frequency and intensity were treated as repeated measures. Bonferroni post hoc analysis
was performed to detect which frequencies showed significant differences.
To determine the most appropriate reference gene among 5 housekeeping genes in RT-
qPCR, fold change (FC) of a given group relative to others was calculated using the formula
of Schmittgen and Livak, 2008:
A Student t test was performed on 2−Ct, and the gene which showed the smallest FC and
largest p-value was selected as a reference gene for RT-qPCR analysis. The average of
normalized mRNA levels in individual cochlear genes in the young-age group are presented
as mean 2−Ct ± SD (standard deviation), where ΔCt = Cttarget gene − Ctreference gene
(Schmittgen and Livak, 2008). Coefficient of variation (CV) was computed as a percentage
of the ratio of the SD to the mean to express the interarray variation.
For gene expression profiling experiments, a comparative Ct method was used to present the
data as FC in expression (Livak and Schmittgen, 2001; Schmittgen and Livak, 2008). The
online Excel-based RT2 Profiler PCR Array Data Analysis Template v3.1, which was
prepared by SABiosciences Corp., was modified and used to evaluate the age-related
cochlear gene expression changes. Specifically, the expression levels of target genes were
first normalized to the reference gene to generate the ΔCt. Then, the following formulas
were used (Schmittgen and Livak, 2008):
When FC < 1, the negative inverse of the FC (−1/FC) was used to express the FC reduction
in expression. A statistical analysis of significance in FC was accomplished with the Student
t test on 2−ΔCt.
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Pearson correlation coefficient (r) and p-values were computed with GraphPad Prism 5
software to investigate the relationship between: (1) gene expression (−ΔCt) and average
ABR thresholds (20, 30, and 40 kHz) or average DPOAE amplitudes (L1/L2 = 65/55 dB
SPL; F2 = 4, 8, 11.3, and 16 kHz), and (2) expression of PCR-significant glutathione- and
thioredoxin-related genes.
3. Results
3.1. ABR and DPOAE
Fig. 2 shows mean (± SD) ABR thresholds at 5, 10, 15, 20, 30, and 40 kHz in the young (n =
10), middle-age (n = 8), and old (n = 10) F344/NHsd rats. When the ABR thresholds exceed
the limit of the testing paradigm (90 dB SPL), the mean ABR threshold is calculated using
90 dB SPL for that datum point. Two-way ANOVA and post hoc tests showed statistically
significant differences in ABR thresholds at 20 (p < 0.01), 30 (p < 0.001), and 40 kHz (p <
0.001) in the comparison of the young- and middle-age groups. Young versus old and
middle versus old comparisons showed statistically significant group difference at all
frequencies (p < 0.001). The results indicated a gradual age-related increase in ABR
thresholds starting from high frequency regions and expanding to low frequencies. This is
consistent with previous studies (Bielefeld et al., 2008; Chen et al., 2009; Hu et al., 2008).
Fig. 3 illustrates mean (± SD) DPOAE input/output (I/O) functions at 4 (A), 8 (B), 11.3 (C),
16 (D), and 20 (E) kHz of F2 frequencies in the young (n = 10), middle (n = 8), and old (n =
10) age groups. A 2-way ANOVA (frequency × age) revealed that DPOAE I/O functions in
all groups were significantly different from each other (p < 0.05) at all frequencies, except
for the comparison of the young- and middle-age groups at 20 kHz. These decreases indicate
the presence of age-related OHC dysfunction starting from at least middle age.
DPOAE/OHC dysfunction from 4 to 16 kHz in the middle-age group was not reflected in
ABR threshold change. However, the old age group showed a significant change in both
ABR and DPOAE compared with the young- and middle-age groups.
Otoscopic examinations revealed cerumen-free external canals in the young-age group,
minimal cerumen in the middle-age group, and severe cerumen accumulation deep in the
external canal near the tympanic membrane in the old animals. Attempts were made to
remove cerumen in some old rats; however, DPOAE amplitude after cleaning either
decreased or remained the same. Therefore, data from these animals were not included in the
data analysis. Due to the difficulty in cerumen removal and lack of any benefit, the decision
was made to not clean the cerumen in the experimental animals to avoid potential damage to
the tympanic membrane. It is conceivable that the decrease in DPOAE amplitudes between
middle and old age may be due, in part, to the accumulation of cerumen; however, we
believe that this is unlikely. First, removing the cerumen failed to increase DPOAE
amplitudes. Second, the age-related decrease in DPOAE amplitudes was frequency-
dependent, being greater at high than low frequencies; cerumen obstruction of the ear canal
would be expected to cause a relatively flat, frequency-independent loss.
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3.2. Cytocochleogram
Fig. 3F shows the mean (n = 3 per group; ± SD) cytocochleogram showing OHC loss in the
young-, middle-, and old-age groups. The upper x-axis shows the frequency that corresponds
to the cochlear location on the lower x-axis. The young- and middle-age groups showed
similar cytocochleograms with little OHC loss, with the possible exception of the middle-
age group which had < 20% OHC loss in the basal turn (> 90% from the apex), which
corresponds to frequencies above 40 kHz. In contrast, the old-age group had a U-shaped
cytocochleogram (more OHC loss in the apical and basal turns and intact OHC in the middle
turn), consistent with previous studies (Bielefeld et al., 2008; Chen et al., 2009; Hu et al.,
2008).
3.3. RT-qPCR array
3.3.1. Reference gene selection—To assess the stability of the reference genes for the
3 age groups used for RT-qPCR analysis, mRNA expression levels of 5 housekeeping genes
in the array (Rplp1, Hprt1, Rpl13a, Ldha, and Actb) were compared between different age
groups (young vs. middle, young vs. old, and middle vs. old) using the Student t test. Table
1 shows p-values and FC values for these reference genes. Ldha, the gene that encodes the
enzyme that catalyzes the conversion of L-lactate to pyruvate in the final step of anaerobic
glycolysis, demonstrated the highest p-values, and the FC values were closest to 1.0 for all
age group comparisons. Therefore, Ldha was selected as a reference gene for RT-qPCR
analysis.
3.4. RT-qPCR gene expression profile
The normalized mRNA levels of individual genes in the young age group are presented as
mean 2−ΔCt ± SD, and the interarray variation is shown as CV, as expressed in percentage
(Table 2). In the young group, hemoglobin alpha, adult chain 2 (Hba-a2) and apolipoprotein
E (Apoe) were the 2 most highly expressed genes among the 84 genes tested. Gpx4 was also
highly expressed in the young cochleae, followed by other isoforms: Gpx3, Gpx1, Gpx2,
Gpx6, Gpx8, Gpx7, and Gpx5, from high to low expression. All 3 types of Cu/Zn-
superoxide dismutase (Sod) genes showed high expression levels in the order of Sod3, Sod1,
and Sod2. The peroxiredoxin (Prdx) family members, Prdx1and Prdx2, were highly
expressed in the young cochleae, followed by Prdx3, Prdx6, Prdx4, and Prdx5.
Table 2 also presents percent CV values in the young group ranging from 4.35% to 37.51%,
with a mean percentage of 15.53. This indicates that individual genes exhibit their own
interarray variation, which may reflect intersubject differences in expression levels of these
genes.
The effects of age on cochlear gene expression are shown in Table 3; comparisons are
shown for young versus middle-age; young versus old, and middle-age versus old.
Significant age-related changes in cochlear gene expression were observed in 13 genes. One
gene, stearoyl-coenzyme A desaturase 1 (Scd1), showed significant downregulation at 21
months of age relative to 2- and 12-month-old rats (−1.18 FC, with p < 0.05, and −1.25 FC,
with p < 0.01, respectively); the gene expression in young- and middle-age groups was
similar.
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Twelve genes, glutathione peroxidase 6 (Gpx6), glutathione S-transferase, kappa 1 (Gstk1),
thioredoxin interacting protein (Txnip), glutathione peroxidase 3 (Gpx3), Gsr, cytoglobin
(Cygb), dual oxidase 2 (Duox2), aminoadipatesemialdehyde synthase (Aass), solute carrier
Family 38, Member 5 (Slc38a5), NAD(P)H dehydrogenease, quinone 1 (Nqo1), vimentin
(Vim), and 24-dehydrocholesterol reductase (Dhcr24), were upregulated in the old age
group, with the mean FC ranging from 1.20 to 1.71. Interestingly, 5 upregulated genes
(Gpx6, Gstk1, Txnip, Gpx3, and Gsr) related to glutathione metabolism and thioredoxin
regulation showed statistically significant upregulation in the middle- age group. Gpx6,
Gstk1, and Txnip were upregulated in middle- and old-age groups relative to young-age
group, but Gsr and Gpx3 mRNA levels were upregulated only in middle- age group relative
to young-age group. Six genes (Cygb, Duox2, Aass, Slc38a5, Nqo1, and Vim) were
upregulated only when the animals reached old age, and Dhcr24 was significantly
upregulated in the old age group compared with the middle-age group.
3.5. Correlation between gene expression and hearing measurements
To examine the relationship between gene expression and hearing measurements, linear
correlation analyses were performed on 13 PCR-significant genes. Table 4 shows Pearson
correlation coefficient (r) and p-values between gene expression (−ΔCt) and average ABR
thresholds (20, 30, and 40 kHz) or average DPOAE amplitudes (L1/L2 = 65/55 dB SPL, F2 =
4, 8, 11.3, and 16 kHz).
Significant linear correlations were found in 8 genes (Scd1, Cygb, Duox2, Aass, Slc38a5,
Nqo1, Vim, and Dhcr24), with either ABR/DPOAE or both. Glutathioneand thioredoxin-
related PCR-significant gene (Gpx6, Gstk1, Txnip, Gpx3, and Gsr) expressions were not
significantly correlated with either ABR thresholds or DPOAE amplitudes, and these are the
5 genes that showed significant upregulation in the middle-age group. Cygb demonstrated
the highest r value and lowest p-values, indicating the strongest correlations with ABR and
DPOAE.
3.6. Correlation between gene expression of PCR-significant genes related to glutathione
and thioredoxin
To examine whether the expression changes in glutathione- and thioredoxin-related genes
(Gpx3, Gpx6, Gsr, Gstk1, and Txnip) are correlated with each other, Pearson correlation
coefficients (r) and p-values were obtained (Table 5). The analyses revealed significant
correlations between Gpx3, Gpx6, Gsr, and Gstk. Expression of Txnip was correlated with
all glutathione-related gene expression, except for Gstk1.
4. Discussion
4.1. The effects of age on hearing and OHC loss
The current results from ABR and DPOAE (Figs. 2 and 3) are consistent with previous
results (Bielefeld et al., 2008; Chen et al., 2009; Hu et al., 2008) that show a decrease in
auditory function with aging and that confirm a discrepancy between reduced DPOAE
amplitudes and the intact OHCs in the middle frequency regions in the old-age group. The
cytocochleograms in the middle- and old-age groups showed no significant OHC loss across
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the 5–40- kHz region of the cochlea, but the DPOAE amplitudes were significantly
decreased in this region. Therefore, the agedependent decreases in DPOAE amplitude are
not likely due to OHC loss but to other possible factors, including decreased expression of
prestin in OHC (Chen et al., 2009); impairment in the stria vascularis and endolymphatic
potential; tectorial membrane distortion (Buckiova et al., 2006); or functional impairment in
inner hair cells/nerve fibers/spiral ganglion cells (Chen et al., 2009).
4.2. Genomic analysis
4.2.1. Cochlear gene profile—The 5 cochlear genes that showed highest mRNA
expression levels in young F344/NHsd rats were Hba-a2, Apoe, Gpx4, Prdx1, and Gpx3.
The gene that showed the highest mRNA expression, Hba-a2, is an oxygen transporter and a
member of the globin family. The second most abundant gene, Apoe, is essential for the
normal catabolism of triglyceride-rich lipoprotein constituents. Apoe is the single most
important risk factor for Alzheimer’s disease (Bertram and Tanzi, 2010). The third and fifth
most abundant genes, Gpx4 and Gpx3, members of the glutathione peroxidase family, are a
part of the glutathione antioxidant system. Both isoforms catalyze the reduction of hydrogen
peroxide or organic peroxides to water or to corresponding alcohols using reduced
glutathione as a specific electron donor substrate (Margis et al., 2008). Gpx4 (phospholipid
Gpx) is bound to membranes and distributed in the nucleus, cytosol, and mitochondria.
Gpx4 has the unique ability to reduce fatty acid and cholesterol hydroperoxides to alcohol
by acting upon peroxidized fatty acid residues within membranes and lipoproteins (Halliwell
and Gutteridge, 2007). Gpx3 (plasma Gpx) is a glycoprotein whose role remains poorly
understood (Brigelius-Flohé, 2006), although it may protect the kidney from oxidative
damage. The fourth most abundant mRNA, Prdx1, is a cytosolic peroxiredoxin that encodes
antioxidant enzymes that reduce hydrogen peroxide and alkyhydroperoxides dependent on
thioredoxin (Watanabe et al., 2010). Interestingly, Prdx2, the only peroxiredoxin isoform
tested in the Hu et al. (2009) study, was 1 of the 3 most highly expressed genes in young
Sprague-Dawley rat cochlea. In addition, Kong et al. (2009) reported decreases in
thioredoxin and thioredoxin reductase gene expression and protein levels in tubby mice (tub/
tub) compared with heterozygous (tub/wt) or wild type (wt/wt). The tubby phenotype
expresses late-onset weight gain and progressive loss of hair cells and retinal degeneration
(Ohlemiller et al., 1995, 1997).
4.2.2. Effects of age on gene expression—In our PCR array experiments, 1 gene
(Scd1) was downregulated, while 12 genes (Gpx6, Gpx3, Gstk1, Txnip, Gsr, Cygb, Duox2,
Aass, Slc38a5, Nqo1, Vim, and Dhcr24) were upregulated due to aging. Based on the age-
related degeneration (i.e., OHC loss) in the cochlea, the interpretation of the significantly
downregulated and upregulated genes needs to be done with caution due to the loss of
specific cell types that contribute to the pool of mRNA.
In the current study, the presence of oxidative stress in rats as young as 12 months of age is
suggested by upregulation of the genes related to glutathione metabolism (Gpx6, Gpx3,
Gstk1, and Gsr). This early upregulation of oxidative stress genes could account for the
early onset of oxidative stress and increases in mitochondrial DNA deletions in the F344/
NHsd’s cochlea at 6 months of age that were reported by the Yin et al. (2007) study.
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Likewise, the significant upregulation of Gpx genes is consistent with upregulation of Gpx
protein activity in the F344/NHsd rats (Coling et al., 2009).
Significant linear correlations among Gpx6, Gpx3, Gstk1, and Gsr gene expressions suggest
that these genes are coregulated by a common factor, probably by an antioxidant response
element (ARE) regulatory region in the promoter region. These genes presumably contain
ARE, which is a cis-acting enhancer sequence in the transcriptional regulatory regions (Nioi
and Hayes, 2004). AREs have cytoprotective functions. In response to oxidative stress,
nuclear factor-erythroid 2 p45-related Factor 2 (Nrf2) binds to ARE and induces expression
of a cluster of genes that encode antioxidant and xenobioticmetabolizing enzymes (Halliwell
and Gutteridge, 2007; Kensler et al., 2007; Nioi and Hayes, 2004). The upregulation of the
ARE-inducible genes in the current study strongly suggests that the cochlear tissue is under
oxidative stress. Given these results, it would be interesting to study the role of the kelchlike
ECH-associated protein 1 (Keap 1)-Nrf2-ARE pathway in ARHL. Txnip, originally
identified as vitamin D3 upregulated Protein 1 (Vdup1), also showed significant
upregulation (Chen and DeLuca, 1994).
Txnip is thought to negatively regulate thioredoxin (Nishiyama et al., 1999), but recent
evidence suggests that Txnip may be involved in lipid/glucose metabolism (Watanabe et al.,
2010) because there is an inverse correlation between its gene expression and longevity
(Chondrogianni et al., 2004; de Candia et al., 2008; Yoshida et al., 2006). The significant
upregulation of Txnip in the middle- and old-age groups may imply a depletion of cochlear
thioredoxin and changes in cochlear lipid/glucose metabolism.
Txnip could conceivably be used as a target to increase cochlear thioredoxin levels to
prevent ARHL. Kong et al. (2009) demonstrated that sulforaphane, a naturally occurring
isothiocyanate, protected against tub-related cochlear degeneration thought to be caused by
downregulation of the thioredoxin antioxidant system. Thioredoxin has not been extensively
studied as a treatment for acquired hearing loss (noise-induced, drug-induced, and age-
related hearing loss). Upregulation of the thioredoxin defense system may be an important
therapeutic option for hearing protection.
Cygb is the gene that had the highest FC and the lowest p-values in the old-age group
relative to the young-age group. Cygb is a member of a newly-discovered class of the
hexacoordinate hemoglobin superfamily. Globins are oxygen- binding molecules, with 5
types identified in vertebrates: hemoglobin, myoglobin, neuroglobin, cytoglobin, and globin
X. Among 4 genes tested (hemoglobin, myoglobin, neuroglobin, and cytoglobin), our study
detected only Cygb and hemoglobin mRNA in the F344/NHsd cochlea.
Cygb showed the strongest linear correlation with ABR/DPOAE, indicating that Cygb may
play an important role in ARHL. In mammals, Cygb mRNA is present at higher
concentrations in cells associated with high metabolic rates such as those in the brain, eyes,
liver, heart, and skeletal muscle (Burmester et al., 2002; Fordel et al., 2004). It is notable
that significant age-related upregulation of Cygb gene expression was reported in human
corneal endothelium in old subjects (>= 50-year-old) compared with young (>= 30-year-old;
Joyce et al., 2011).
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Cygb may be a promising target for ARHL prevention because it works not only as a ROS
scavenger but also as a generator of an antioxidant response. Initially, Cygb was suggested
to play an important role in fibrogenesis in the liver and in the protection of cells from
oxidative stress by functioning as a ROS scavenger (Fordel et al., 2007; Li et al., 2007).
New evidence indicates that Cygb interacts with and oxidizes lipids under an oxidative
environment, generating cell-signaling lipid molecules, inducing cell-signaling pathways,
and creating an antioxidant response to the oxidative stress (Reeder et al., 2011).
4.2.3. Relation between gene expression and hearing measurements—Linear
correlation analyses were used to investigate whether there were significant relationships
between gene expression and auditory function, similar to what was done with large-scale
gene arrays in the CBA mouse cochlea (Tadros et al., 2008). Most of the significant gene
expression changes were strongly correlated with hearing measurements. This suggests that
these genes may contribute significantly to ARHL. However, this interpretation is not
simple or straightforward because many of the gene expression changes associated with
ARHL have cytoprotective functions, or have both survival and apoptotic functions. The
upregulation of cytoprotective genes could be a natural response to counteract oxidative
stress that leads to ARHL. At some point, however, the survival-promoting aspects of some
genes may switch to apoptosis when cell survival is no longer a viable option.
Interestingly, the expression changes of the glutathionerelated genes were not linearly
related to the deterioration in ABR and DPOAE. This occurred because the expression
levels of glutathione-related genes were upregulated early and did not increase further with
advancing age, whereas auditory function progressively deteriorated with advancing age.
These results suggest that the glutathione antioxidant system is the first defense that is
upregulated to suppress oxidative stress and minimize ARHL and tissue damage. However,
because ARHL continues to accumulate, the upregulation of glutathione genes is not
sufficient to fully suppress oxidative stress, leading to further progression of ARHL. In other
words, upregulation of glutathione genes is not sufficient to completely protect the cochlea
in ARHL. Because the mean FCs measured in these glutathione-related genes were
relatively low, supplementing of exogenous glutathione-related antioxidant agents could be
a reasonable option for ARHL treatment.
4.3. Future studies with rat ARHL models
The current study was designed to serve as the first phase to identify significant cochlear
genes in the oxidative stress and antioxidant defense pathway in relation to ARHL in the
F344/NHsd rat. Our results identified specific subsets of oxidative stress genes that appear
to play an important role in ARHL in the F344/NHsd rats. The RT-qPCR array experiments
revealed significant downregulation in 1 gene (Scd1) and upregulation in 12 genes (Gpx6,
Gpx3, Gstk1, Txnip, Gsr, Cygb, Duox2, Aass, Slc38a5, Nqo1, Vim, and Dhcr24) due to
aging. Among these genes, Txnip and Cygb as well as glutathione-related genes seem to be
promising targets for ARHL prevention.
Because the current gene expression studies were conducted with tissues from the whole
cochlea, significant gene expression changes limited to a particular region of the cochlea or
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specific cell type would likely have been overlooked in the current study. However, because
our gene profiling detected age-related gene expression changes in the whole cochlear
mRNA, the changes we observed must be occurring at high levels in specific regions or cell
types, or at moderate levels across most cochlear tissues. Regardless of whether the changes
are region-specific or global in nature, the observed changes provide novel mechanistic
insights and potential opportunities for therapeutic intervention.
There is an inborn weakness of all gene array studies, which is that differences in mRNA
levels do not necessarily translate to changes in protein levels. Therefore, future
investigations of protein gene expression changes in specific cochlear cell types or tissue
compartments are imperative, and immunostaining will offer the possibility of identifying
significant regional changes that are likely to be essential for achieving a full picture of
oxidative stress in the F344/NHsd rat.
ARHL is a complex sensory disorder caused by the interaction of a variety of factors,
including genetic and nongenetic factors (Van Eyken et al., 2007). Unlike our current lack of
knowledge of the rat ARHL model, the genetic causes of ARHL are well understood in
mouse ARHL models. This understanding makes it easier to investigate whether oxidative
stress is an initial cause or a downstream event in ARHL. For example, CBA/J mice carry
the age-related hearing loss (Ahl)-resistant gene (Johnson et al., 1997) and develop ARHL
much later in life compared with C57BL/6J and DBA/2J, which show cadherin23 deficits in
stereocilia and the involvement of the Ahl1 locus (Johnson et al., 2008; Nemoto et al., 2004;
Noben-Trauth and Johnson, 2009). Age-related increase in immunoreactivity of selected
oxidative stress-related markers (glutathione-conjugated proteins, anti-4-hydroxynonenal,
anti-3-nitrotyrosine) was reported in CBA/J mice (Jiang et al., 2007), indicating that
oxidative stress was an initial cause of cochlear tissue degeneration, unlike in C57BL/6J and
DBA/2J mice.
The genetic contributions to ARHL in the F344/NHsd have not been fully investigated at
this point. It is possible that certain gene alleles in the F344/NHsd initially cause ARHL, and
oxidative stress may be a downstream event. Until we have a fuller understanding of the
genetic contributions to ARHL in the F344/NHsd, it is difficult to designate an oxidative
stress or antioxidant-related gene as a causative “presbycusis gene” in this model.
Nevertheless, we can engineer primary defects in antioxidant genes using a knockout (KO)
model to study the effects of these genes on ARHL. Studies of ARHL in KO mouse models
suggest that the effects of targeted deletions of particular antioxidant genes, such as Gpx1
and Sod1, may be confounded by genetic backgrounds (Johnson et al., 2010; Keithley et al.,
2005; McFadden et al., 1999a, 1999b; Ohlemiller et al., 1999, 2000), and this can mimic the
expected interplay of ARHL-inducing genes and antioxidant defense genes in humans.
Recently, a knockout rat became available and Knockout Rat Consortium is an excellent
website for cutting-edge technologies (http://www.knockoutrat.org/). The F344 rat and other
rat strains, such as Long Evans rats, may offer alternative models or a complement to mice
by providing different genetic backgrounds that contribute to ARHL. To realize such
research, a more complete understanding of rat ARHL model genomes is critical.
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Fig. 1.
Oxidative stress and age-related hearing loss (ARHL). Key: mDNA, mitochondrial DNA,
ROS, reactive oxygen species.
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Fig. 2.
Mean (± SD) auditory brainstem response (ABR) thresholds at 5, 10, 15, 20, 30, and 40 kHz
in the young (open circles), middle-aged (gray circles), and old (filled circles) F344/NHsds.
* p> 0.05. ** p < 0.01. *** p < 0.001.
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Fig. 3.
Mean (± SD) distortion product otoacoustic emission (DPOAE) input/output (I/O) functions
at different F2 frequencies in young-, middle-, and old age groups (A–E); Mean (± SD)
percentage of outer hair cell (OHC) loss as a function of distance from the apex (%) in
young-, middle-, and old-age groups (F). The upper x-axis shows the frequency that
corresponds to the cochlear location on the lower x-axis.
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Table 1
p-values and fold change (FC) for candidate reference genes.
Official Symbol Middle vs. young Old vs. young Old vs. middle
Rplp1 0.137 (1.26) 0.110 (1.23) 0.828 (−1.03)
Hprt1 0.084 (1.24) 0.404 (1.11) 0.278 (−1.12)
Rpl13a 0.042 (1.37) 0.080 (1.24) 0.318 (−1.10)
Ldha 0.938 (1.02) 0.846 (1.03) 0.940 (1.02)
Actb 0.189 (1.24) 0.275 (1.15) 0.654 (−1.07)
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Table 2
Normalized mRNA levels of individual gene in the young-age group expressed as mean 2ΔCt ± SD, and the
interarray variation shown as coefficient of variation (CV) as a percentage
Official Symbol Mean 2−ΔCt ± SD %CV
Hba-a2 13.236 ± 3.134 23.68
Apoe 13.029 ± 1.063 8.16
Gpx4 5.671 ± 0.264 4.66
Prdx1 4.203 ± 0.207 4.94
Gpx3 4.039 ± 0.369 9.14
Sod3 3.709 ± 0.384 10.35
Prdx2 3.632 ± 0.765 21.08
Ctsb 3.581 ± 0.837 23.37
Scd1 3.537 ± 0.237 6.69
Sod1 2.586 ± 0.359 13.87
Tmod1 2.433 ± 0.169 6.93
Sod2 2.189 ± 0.223 10.19
Gpx1 1.939 ± 0.184 9.48
Psmb5 1.854 ± 0.353 19.06
Park7 1.793 ± 0.266 14.81
Slc41a3 1.088 ± 0.154 14.20
Gpx2 1.027 ± 0.087 8.47
Gpx6 0.796 ± 0.067 8.45
Prdx3 0.777 ± 0.063 8.08
Vim 0.771 ± 0.119 15.46
Prnp 0.705 ± 0.100 14.18
Txnip 0.625 ± 0.082 13.11
Aass 0.615 ± 0.035 5.72
Slc38a1 0.601 ± 0.122 20.23
Prdx6 0.578 ± 0.051 8.85
Ppp1r15b 0.536 ± 0.078 14.55
Ccs 0.502 ± 0.033 6.51
Gstk1 0.466 ± 0.033 7.19
Idh1 0.452 ± 0.058 12.84
Gpx8 0.450 ± 0.027 6.01
Gsr 0.434 ± 0.048 11.12
Prdx4 0.405 ± 0.046 11.26
Cat 0.371 ± 0.016 4.35
Apc 0.364 ± 0.039 10.61
Gab1 0.358 ± 0.066 18.45
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Official Symbol Mean 2−ΔCt ± SD %CV
Nxn 0.354 ± 0.051 14.47
Prdx5 0.306 ± 0.058 18.81
Ift172 0.185 ± 0.037 19.80
Ercc2 0.167 ± 0.028 16.57
Xpa 0.167 ± 0.032 19.19
Aqr 0.164 ± 0.015 9.37
Als2 0.113 ± 0.023 20.10
Txnrd2 0.103 ± 0.009 8.93
Ehd2 0.097 ± 0.020 20.83
Ercc6 0.092 ± 0.016 17.26
Gpx7 0.076 ± 0.008 11.13
Dnm2 0.075 ± 0.011 15.31
Txnrd1 0.069 ± 0.011 16.40
Ptgs2 0.055 ± 0.015 27.33
Fancc 0.049 ± 0.009 17.82
Nqo1 0.040 ± 0.007 18.34
Ncf1 0.040 ± 0.008 20.42
Dhcr24 0.037 ± 0.009 23.49
Nudt1 0.033 ± 0.006 17.50
Slc38a5 0.030 ± 0.006 19.13
Cygb 0.023 ± 0.003 12.93
Nudt15 0.019 ± 0.004 20.98
Ncf2 0.014 ± 0.003 23.18
Noxa1 0.011 ± 0.002 20.61
Ucp3 0.010 ± 0.001 7.56
Ptgs1 0.010 ± 0.003 29.16
Kif9 0.009 ± 0.002 18.72
Epx 0.008 ± 0.003 33.35
Fmo2 0.008 ± 0.001 16.53
RGD1560658 0.007 ± 0.002 24.63
Nos2 0.007 ± 0.002 37.51
Slc38a4 0.005 ± 0.001 17.85
Duox2 0.004 ± 0.001 22.19
Zmynd17 0.004 ± 0.0004 9.56
Gpx5 0.004 ± 0.001 29.57
Duox1 0.002 ± 0.0003 20.14
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Table 4
Pearson correlation coefficients (r) and p-values between gene expression of PCR-significant genes and
hearing measurements
Official symbol Average ABR, 20, 30, 40 kHz (r, p) Average DPOAE, 4, 8, 11.3, 16 kHz (r, p)
Gpx6 0.414, 0.181 −0.353, 0.261
Gstk1 0.359, 0.252 −0.313, 0.322
Txnip 0.432, 0.161 −0.437, 0.156
Gpx3 0.470, 0.145 −0.301, 0.368
Gsr 0.172, 0.593 −0.256, 0.422
Cygb 0.937, <0.0001*** −0.914, <0.0001***
Duox2 0.651, 0.022* −0.723, 0.008**
Aass 0.747, 0.008** −0.709, 0.015*
Slc38a5 0.621, 0.031* −0.743, 0.006**
Nqo1 0.700, 0.011* −0.773, 0.003**
Vim 0.750, 0.005** −0.747, 0.005**
Dhcr24 0.522, 0.082
−0.623, 0.031*
Scd1
−0.703, 0.011* 0.630, 0.028*
Average ABR thresholds at 20, 30, and 40 kHz or average DPOAE amplitudes at L1/L2 = 65/55 dB SPL and F2 = 4, 8, 11.3, and 16 kHz)
Key: ABR, auditory brainstem response; DPOAE, distortion product otoacoustic emission; PCR, polymerase chain reaction, SPL, sound pressure
level.
*
p < 0.05;
**
p < 0.01;
***
p < 0.001.
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